HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Diazepam versus midazolam as pre-endoscopic medication].

Abstract
A prospective randomized double blind study was carried out on 60 patients undergoing elective gastrointestinal endoscopy. Patients in group A were sedated with diazepam (0.15 mg/kg) and those in group B received midazolam (0.10 mg/kg). There were no differences between the groups in age, sex, previous drug intake, level of anxiety prior to the procedure and from the endoscopist point of view the easiness to perform the studies. The group of patients who received midazolam (B) showed a significantly greater sedation, had less pain in the site of injection, their retrograde amnesia was more effective and tolerated much better the overall procedure (p < 0.05). There were no complications in either group. The cost per dosage was 2:1 greater with midazolam. It is concluded that midazolam has some advantages over diazepam used for sedation of patients undergoing gastrointestinal endoscopy. The time for recovery and cost are its disadvantages.
AuthorsJ A Córdova Villalobos, R Rojas Hernández, T M Hernández Ortiz, E J Ramírez Barba
JournalRevista de gastroenterologia de Mexico (Rev Gastroenterol Mex) 1992 Oct-Dec Vol. 57 Issue 4 Pg. 238-41 ISSN: 0375-0906 [Print] Mexico
Vernacular TitleDiazepam versus midazolam como medicación pre-endoscópica.
PMID1308305 (Publication Type: Clinical Trial, Comparative Study, English Abstract, Journal Article, Randomized Controlled Trial)
Chemical References
  • Diazepam
  • Midazolam
Topics
  • Adolescent
  • Adult
  • Conscious Sedation
  • Cross-Sectional Studies
  • Diazepam
  • Double-Blind Method
  • Endoscopy, Gastrointestinal
  • Female
  • Humans
  • Male
  • Midazolam
  • Middle Aged
  • Premedication
  • Prospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: